114 related articles for article (PubMed ID: 29503418)
1. [Newly Designed Water Treatment Systems for Hospital Effluent].
Azuma T
Yakugaku Zasshi; 2018; 138(3):289-296. PubMed ID: 29503418
[TBL] [Abstract][Full Text] [Related]
2. Environmental fate of pharmaceutical compounds and antimicrobial-resistant bacteria in hospital effluents, and contributions to pollutant loads in the surface waters in Japan.
Azuma T; Otomo K; Kunitou M; Shimizu M; Hosomaru K; Mikata S; Ishida M; Hisamatsu K; Yunoki A; Mino Y; Hayashi T
Sci Total Environ; 2019 Mar; 657():476-484. PubMed ID: 30550911
[TBL] [Abstract][Full Text] [Related]
3. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
[TBL] [Abstract][Full Text] [Related]
4. Hindsight rather than foresight: reality versus the EU draft guideline on pharmaceuticals in the environment.
O'Brien E; Dietrich DR
Trends Biotechnol; 2004 Jul; 22(7):326-30. PubMed ID: 15245903
[TBL] [Abstract][Full Text] [Related]
5. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
Verlicchi P; Al Aukidy M; Galletti A; Petrovic M; Barceló D
Sci Total Environ; 2012 Jul; 430():109-18. PubMed ID: 22634557
[TBL] [Abstract][Full Text] [Related]
6. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
Kümmerer K
Schriftenr Ver Wasser Boden Lufthyg; 2000; 105():59-71. PubMed ID: 10842795
[TBL] [Abstract][Full Text] [Related]
7. The occurrence and distribution of pharmaceutical compounds in the effluents of a major sewage treatment plant in Northern Taiwan and the receiving coastal waters.
Fang TH; Nan FH; Chin TS; Feng HM
Mar Pollut Bull; 2012 Jul; 64(7):1435-44. PubMed ID: 22608946
[TBL] [Abstract][Full Text] [Related]
8. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil.
Li WC
Environ Pollut; 2014 Apr; 187():193-201. PubMed ID: 24521932
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
10. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
[TBL] [Abstract][Full Text] [Related]
11. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review.
Kümmerer K
Chemosphere; 2001 Nov; 45(6-7):957-69. PubMed ID: 11695619
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
Boyd GR; Reemtsma H; Grimm DA; Mitra S
Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceuticals in on-site sewage effluent and ground water, Western Montana.
Godfrey E; Woessner WW; Benotti MJ
Ground Water; 2007; 45(3):263-71. PubMed ID: 17470115
[TBL] [Abstract][Full Text] [Related]
14. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.
Heberer T
Toxicol Lett; 2002 May; 131(1-2):5-17. PubMed ID: 11988354
[TBL] [Abstract][Full Text] [Related]
15. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
16. Effluent-dominated streams. Part 2: Presence and possible effects of pharmaceuticals and personal care products in Wascana Creek, Saskatchewan, Canada.
Waiser MJ; Humphries D; Tumber V; Holm J
Environ Toxicol Chem; 2011 Feb; 30(2):508-19. PubMed ID: 21072845
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals and personal care products (PPCPs) in Australia's largest inland sewage treatment plant, and its contribution to a major Australian river during high and low flow.
Roberts J; Kumar A; Du J; Hepplewhite C; Ellis DJ; Christy AG; Beavis SG
Sci Total Environ; 2016 Jan; 541():1625-1637. PubMed ID: 26456435
[TBL] [Abstract][Full Text] [Related]
18. Source estimation of pharmaceuticals based on catchment population and in-stream attenuation in Yodo River watershed, Japan.
Hanamoto S; Nakada N; Yamashita N; Tanaka H
Sci Total Environ; 2018 Feb; 615():964-971. PubMed ID: 29751447
[TBL] [Abstract][Full Text] [Related]
19. The presence of acidic and neutral drugs in treated sewage effluents and receiving waters in the Cornwallis and Annapolis River watersheds and the Mill CoveSewage Treatment Plant in Nova Scotia, Canada.
Crouse BA; Ghoshdastidar AJ; Tong AZ
Environ Res; 2012 Jan; 112():92-9. PubMed ID: 22178020
[TBL] [Abstract][Full Text] [Related]
20. Strategies for decolorization and detoxification of pulp and paper mill effluent.
Garg SK; Tripathi M
Rev Environ Contam Toxicol; 2011; 212():113-36. PubMed ID: 21432056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
